What topics does this cannabis study cover?

This study covers research on: Addiction, Endocannabinoid, Inflammation, Neuroprotection.

Addiction Endocannabinoid Inflammation Neuroprotection

CBD and redox balance emerge as targets for alcohol addiction recovery

Q: Where was this research published?

Published in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie on June 6, 2026.

Mapping a therapeutic redox ceRNA network in alcohol use disorder: Systems biology insights for drug repurposing.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie • June 6, 2026 • Review • Moderately Relevant

🤖

AI Summary

This groundbreaking systems biology study maps the molecular mechanisms linking oxidative stress to alcohol use disorder (AUD), revealing how imbalances in reactive oxygen species disrupt multiple brain circuits simultaneously. Researchers integrated genetic and molecular data to construct a "competing endogenous RNA" network—essentially a map of how non-coding RNAs regulate gene expression during alcohol-induced damage. The analysis identified 12 long non-coding RNAs, 9 microRNAs, and 13 protein-coding genes working together to amplify oxidative stress and neuroinflammation, with independent confirmation in human brain tissue validating these theoretical findings.

The most striking discovery was the network's direct connection to addiction-related neurotransmitter pathways, including dopaminergic, glutamatergic, GABAergic, and critically, endocannabinoid systems. This finding suggests oxidative stress doesn't just cause general brain damage—it specifically hijacks the brain's reward and motivation circuitry through multiple molecular pathways. The study identified several existing drugs that could reverse these mechanisms, including CBD (cannabidiol), disulfiram, melatonin, and others, suggesting potential therapeutic interventions.

This research has profound implications for AUD treatment and cannabis research specifically. By positioning cannabidiol alongside established pharmaceuticals as a candidate for targeting redox-mediated neuroinflammation, the study provides a molecular framework for understanding how CBD might help with alcohol addiction recovery. The endocannabinoid system involvement suggests that restoring proper redox balance could normalize the dysregulated reward circuitry underlying addiction, opening new avenues for combined or alternative therapeutic approaches beyond conventional medications.

📄 Original Abstract

Alcohol use disorder (AUD) is a chronic neuropsychiatric condition in which oxidative stress drives ethanol‑induced neurotoxicity and neuroimmune dysregulation. However, the post‑transcriptional roles of non‑coding RNAs (ncRNAs) in redox imbalance remain poorly understood. In this study, we integrated redox‑related gene signatures from published transcriptomic sources (meta‑analyses and original datasets) with lncRNA and miRNA expression profiles to identify differentially expressed redox‑associated mRNAs, lncRNAs, and miRNAs. Using these features, we constructed a redox‑centered competing endogenous RNA (ceRNA) network. This network revealed coordinated upregulation of lncRNAs and mRNAs alongside miRNA suppression, consistent with ceRNA‑mediated derepression. The final network comprised 12 lncRNAs, 9 miRNAs, and 13 mRNAs, and uncovered modules linked to oxidative stress, neuroinflammation, endoplasmic reticulum stress, and synaptic remodeling. Redox‑related miRNAs were significantly enriched in addiction‑associated neurotransmitter pathways (dopaminergic, glutamatergic, GABAergic, and endocannabinoid), indicating a systems‑level impact of redox imbalance on AUD neurocircuitry. Protein‑protein interaction analysis identified key redox hubs involved in antioxidant defense, reactive oxygen species production, and inflammasome activation. Independent proteomic validation in human AUD brain tissue confirmed concordant regulation of superoxidase 2, glutathione peroxidase, and NADH quinone dehydrogenase 1, directly supporting these hubs. Toxicogenomic and network pharmacology analyses further linked these redox‑sensitive nodes to alcohol‑induced oxidative damage and to clinically relevant compounds (disulfiram, cannabidiol, melatonin, carbamazepine, valproic acid). Collectively, this work establishes the first integrative framework for ceRNA‑mediated redox control in AUD, elucidates mechanisms of oxidative stress‑driven neuroinflammation, and identifies potential biomarkers and therapeutic targets.

Paper Type

📚 Review

Publication

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 6, 2026
PMID: 42250388
DOI: 10.1016/j.biopha.2026.119633

Authors (4)

Soudabeh Kavousipour Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Behnam Khodadoust Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Fatemeh Keshavarzi Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Electronic address: f.keshavarzi@hums.ac.ir.
Ebrahim Eftekhar Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Electronic address: ebrahim.eftekhar@hums.ac.ir.